TY - JOUR
T1 - Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing
AU - Izumi, Kanako
AU - Kurosaka, Daijiro
AU - Iwata, Takeshi
AU - Oguchi, Yoshihisa
AU - Tanaka, Yasuhiko
AU - Mashima, Yukihiko
AU - Tsubota, Kazuo
PY - 2006/2
Y1 - 2006/2
N2 - PURPOSE. The involvement of downstream messengers of transforming growth factor (TGF)-β in the differentiation of corneal fibroblasts into myofibroblasts was investigated. The effects of insulin-like growth factor (IGF)-I and insulin-like growth factor binding protein (IGFBP)-3 upregulated by TGF-β were examined in human corneal fibroblasts, and the possible involvement of IGF axis components in corneal wound healing was assessed in a mouse model. METHODS. Human corneal fibroblasts were incubated with TGF-β2 or IGF-I, to investigate IGF-I, IGF-II, IGFBP-3, type I collagen, and α-smooth muscle actin (α-SMA) mRNA, as well as IGFBP-3 protein expression, during myofibroblast differentiation. DNA synthesis was evaluated with a 5-bromo-2́-deoxyuridine (BrdU) incorporation assay. IGFBP-3 mRNA expression, protein expression, and immunolocalization were investigated in mouse corneas after photorefractive keratectomy (PRK). RESULTS. TGF-β2 treatment induced expression of IGF-I and IGFBP-3 mRNA and of IGFBP-3 protein in human corneal fibroblasts. TGF-β2 and IGF-I both stimulated expression of type I collagen. TGF-β2 but not IGF-I potently stimulated α-SMA mRNA expression. IGF-I potently stimulated basal DNA synthesis, whereas IGFBP-3 inhibited it. IGF-I potently stimulated proliferation of TGF-β2-activated myofibroblasts without reversing the activated fibrogenic phenotype, whereas IGFBP-3 suppressed IGF-I-induced proliferation of corneal fibroblasts. IGFBP-3 mRNA and protein increased in mouse corneas soon after PRK, when in vivo immunostaining of the corneas showed expression of IGFBP-3 in the deep layer of the corneal stroma. CONCLUSIONS. These results suggest that during corneal wound healing, TGF-β stimulates IGF axis components, whereas IGFBP-3 may modulate IGF-I-induced myofibroblast proliferation to suppress corneal mesenchymal overgrowth.
AB - PURPOSE. The involvement of downstream messengers of transforming growth factor (TGF)-β in the differentiation of corneal fibroblasts into myofibroblasts was investigated. The effects of insulin-like growth factor (IGF)-I and insulin-like growth factor binding protein (IGFBP)-3 upregulated by TGF-β were examined in human corneal fibroblasts, and the possible involvement of IGF axis components in corneal wound healing was assessed in a mouse model. METHODS. Human corneal fibroblasts were incubated with TGF-β2 or IGF-I, to investigate IGF-I, IGF-II, IGFBP-3, type I collagen, and α-smooth muscle actin (α-SMA) mRNA, as well as IGFBP-3 protein expression, during myofibroblast differentiation. DNA synthesis was evaluated with a 5-bromo-2́-deoxyuridine (BrdU) incorporation assay. IGFBP-3 mRNA expression, protein expression, and immunolocalization were investigated in mouse corneas after photorefractive keratectomy (PRK). RESULTS. TGF-β2 treatment induced expression of IGF-I and IGFBP-3 mRNA and of IGFBP-3 protein in human corneal fibroblasts. TGF-β2 and IGF-I both stimulated expression of type I collagen. TGF-β2 but not IGF-I potently stimulated α-SMA mRNA expression. IGF-I potently stimulated basal DNA synthesis, whereas IGFBP-3 inhibited it. IGF-I potently stimulated proliferation of TGF-β2-activated myofibroblasts without reversing the activated fibrogenic phenotype, whereas IGFBP-3 suppressed IGF-I-induced proliferation of corneal fibroblasts. IGFBP-3 mRNA and protein increased in mouse corneas soon after PRK, when in vivo immunostaining of the corneas showed expression of IGFBP-3 in the deep layer of the corneal stroma. CONCLUSIONS. These results suggest that during corneal wound healing, TGF-β stimulates IGF axis components, whereas IGFBP-3 may modulate IGF-I-induced myofibroblast proliferation to suppress corneal mesenchymal overgrowth.
UR - http://www.scopus.com/inward/record.url?scp=33644872861&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644872861&partnerID=8YFLogxK
U2 - 10.1167/iovs.05-0097
DO - 10.1167/iovs.05-0097
M3 - Article
C2 - 16431955
AN - SCOPUS:33644872861
SN - 0146-0404
VL - 47
SP - 591
EP - 598
JO - Investigative Ophthalmology
JF - Investigative Ophthalmology
IS - 2
ER -